Amgen Inc.
CH ˙ SWX ˙ NL0000888691
SecurityCH:AMGN / Amgen Inc.
InstitutionBouchey Financial Group Ltd
Latest Disclosed Ownership1,825 shares
Latest Disclosed Value $ 648,970
Bouchey Financial Group Ltd reports 3.58% increase in ownership of AMGN / Amgen Inc.

On April 13, 2026 - Bouchey Financial Group Ltd filed a 13F-HR form disclosing ownership of 1,825 shares of Amgen Inc. (CH:AMGN) valued at $648,970 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 16, 2026 disclosing 1,762 shares of Amgen Inc.. This represents a change in shares of 3.58% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-13 2026-03-31 13F AMGEN COM 031162100 1,825 63 3.58 649 12.50 0.0476
2026-01-16 2025-12-31 13F AMGEN COM 031162100 1,762 -4 -0.23 577 15.66 0.0433
2025-11-12 2025-09-30 13F AMGEN COM 031162100 1,766 72 4.25 498 5.51 0.0384
2025-08-08 2025-06-30 13F AMGEN COM 031162100 1,694 -71 -4.02 473 -14.03 0.0393
2025-05-09 2025-03-31 13F AMGEN COM 031162100 1,765 20 1.15 550 20.93 0.0496
2025-02-05 2024-12-31 13F AMGEN COM 031162100 1,745 7 0.40 455 -18.93 0.0397
2024-10-24 2024-09-30 13F AMGEN COM 031162100 1,738 33 1.94 560 5.26 0.0501
2024-07-12 2024-06-30 13F AMGEN COM 031162100 1,705 20 1.19 532 11.06 0.0505
2024-04-23 2024-03-31 13F AMGEN COM 031162100 1,685 0 0.00 479 -1.24 0.0472
2024-01-18 2023-12-31 13F AMGEN COM 031162100 1,685 344 25.65 485 34.72 0.0520
2023-10-24 2023-09-30 13F AMGEN COM 031162100 1,341 360 36.70 361 65.90 0.0442
2023-07-13 2023-06-30 13F AMGEN COM 031162100 981 0 0.00 218 -8.44 0.0264
2023-05-02 2023-03-31 13F AMGEN COM 031162100 981 0 0.00 237 -7.78 0.0313
2023-01-24 2022-12-31 13F AMGEN COM 031162100 981 981 258 0.0371
2022-10-27 2022-09-30 13F AMGEN COM 031162100 0 -1,057 -100.00 0 -100.00
2022-07-26 2022-06-30 13F AMGEN COM 031162100 1,057 76 7.75 257 8.44 0.1510
2022-05-06 2022-03-31 13F Amgen Com 031162100 981 981 237 0.0318
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.